The following new grants were awarded to JCCC members, announced in August 2012:
Principal Investigator:
Arab, Lenore
Sponsor Name: University Of North Carolina
Award Title: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of Tabalumab in Combination with Bortezomib and Dexamethasone in Patients with Previously Treated Multiple Myeloma
Principal Investigator: Bastani, Roshan
Sponsor Name: NIH/National Cancer Institute
Award Title: Increasing HPV Vaccine Uptake in a Low Income Ethnic Minority Population
Principal Investigator: Belin, Thomas
Sponsor Name: Amgen
Award Title: Amgen Pre-Doctoral Fellowship in Biostatistics
Principal Investigator: Crooks, Gay
Sponsor Name: NIH/National Heart, Lung, and Blood Institute
Award Title: Defining the Earliest Stages of Lymphoid Commitment in Human Bone Marrow
Principal Investigator: Di Carlo, Dino
Sponsor Name: National Science Foundation
Award Title: Career: High-Throughput Single-Cell Biophysics
Principal Investigator: Eibl, Guido
Sponsor Name: NIH/National Cancer Institute
Award Title: Targeting Diet-Induced Promotion of Kras-Initiated Pancreatic Adenocarcinoma
Principal Investigator: Elashoff, Robert
Sponsor Name: Cedars-Sinai Medical Center
Award Title: Planning a Multi-Center Clinical Trial of Pde5 Inhibition for Duchenne Muscular Dystrophy
Principal Investigator: Eradat, Herbert
Sponsor Name: Gilead Sciences, Inc.
Award Title: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Efficacy and Safety of Gs-1101 (Cal-101) in Combination with Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia
Principal Investigator: Federman, Noah
Sponsor Name: St. Baldrick's Foundation
Award Title: Developmental of Multispecific Nano Particles To Target Pediatric Sarcomas
Principal Investigator: Graeber, Thomas
Sponsor Name: American Cancer Society, Incorporated
Award Title: Delineating Braf Inhibitor Resistance Mechanisms Using Proteomic Profiling
Principal Investigator: Gwack, Yousang
Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases
Award Title: New Class of Immunomodulator, Crac Channel Blockers
Principal Investigator: Herschman, Harvey
Sponsor Name: American Society of Hematology
Award Title: Zaiss, Anne: The Role of Heparan Sulfate and Hepatic Lipoprotein Receptors on Factor X-Dependent Adenovirus Transduction in Vivo
Principal Investigator: Hurvitz, Sara
Sponsor Name: Boehringer Ingelheim Pharmaceuticals, Inc
Award Title: Open-Label, Phase Ii Trial of Afatinib with or without Vinorelbine for The Treatment of Her2-Overexpressing Inflammatory Breast Cancer
Principal Investigator: Hurvitz, Sara
Sponsor Name: Boehringer Ingelheim Pharmaceuticals, Inc.
Award Title: Lux-Breast 3: Randomized Phase Ii Study of Afatinib Alone or in Combination with Vinorelbine Versus Investigator’s Choice of Treatment in Patients with Her2-Positive Breast Cancer with Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy
Principal Investigator: Irwin, Michael
Sponsor Name: NIH/National Cancer Institute
Award Title: Sleep, Inflammation, and Depression Occurrence in Breast Cancer Survivors
Principal Investigator: Kohn, Donald
Sponsor Name: NIH/National Institute of Allergy and Infectious Diseases
Award Title: EFS-Ada Lentiviral Vector Transduction of Bone Marrow Cd34+ Cells for Ada-Scid
Principal Investigator: Kominski, Gerald
Sponsor Name: Blue Shield of Cal Res & Educ Fdn.
Award Title: Low Income Health Program (Lihp) Evaluation
Principal Investigator: Liau, Linda
Sponsor Name: American Brain Tumor Association
Award Title: Chou, Arthur: Abnormal Dna Methylation and Retinoic Acid Signaling in Gliomas with Isocitrates Dehydrogenase 1 (Idh1) Mutation
Principal Investigator: Liau, Linda
Sponsor Name: American Assn of Neurological Surgeons
Award Title: Everson, Richard: Immunosensitization and Adoptive Transfer of Ny-Eso-1 Tcr Engineered Cells for Treatment of Glioblastoma
Principal Investigator: Lo, Roger
Sponsor Name: Association of American Cancer Institute
Award Title: Shi, Hubing: a Pdgfrbeta-Egfr Hetero-Complex in B-Raf Mutant Melanomas with Acquired Resistance To B-Raf Inhibition
Principal Investigator: Maliski, Sally
Sponsor Name: NIH/National Institute of Nursing Research
Award Title: Chang, Nancy Takatsuka:Understanding Barriers To Self-Management Among Latino Adolescents with Type 2 Dm
Principal Investigator: Memarzadeh, Sanaz
Sponsor Name: Sidney Kimmel Cancer Center (Incl Sidney Kimmel Cancer Center)
Award Title: Progesterone Signaling As a Regulator of Hormone Sensitivity in The Endometrial Tumor Microenvironment
Principal Investigator: Pietras, Richard
Sponsor Name: Gateway for Cancer Research
Award Title: Clinical Investigation of Conbination Treatment with An Aromatase Inhibitor (Exemestane) and Carboplatin-Based Therapy in Postmenopausal Women with Advanced Non-Small Cell Lung Cancer
Principal Investigator: Ponce, Ninez
Sponsor Name: Aetna Life Insurance
Award Title: Disparities in Utilization of Gene Expression Profiling and Subsequent Chemotherapy Decisions
Principal Investigator: Rao, Jian
Sponsor Name: Clovis Oncology
Award Title: Analytical Validation of The Sp120 Hent1 Lab Developed Test (Ldt)
Principal Investigator: Schiller, Gary
Sponsor Name: Eli Lilly and Company
Award Title: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of Tabalumab in Combination with Bortezomib and Dexamethasone in Patients with Previously Treated Multiple Myeloma
Principal Investigator: Schiller, Gary
Sponsor Name: Bristol-Myers Squibb Company
Award Title: Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone with or without Elotuzumab in Subjects with Previously Untreated Multiple Myeloma
Principal Investigator: Sun, Ren
Sponsor Name: Margaret E. Early Medical Research Trust
Award Title: Systematic Mapping of Anti-Ifn Functional Sequences on The Hepatitis C Virus (Hcv) Genome
Principal Investigator: Wainberg, Zev
Sponsor Name: Biomarin Pharmaceuticals Inc.
Award Title: Phase 1, First in Human, Single-Arm, Open-Label Study of once a Day, orally Administered Bmn 673 in Patients with Advanced or Recurrent Solid Tumors
Principal Investigator: Wainberg, Zev
Sponsor Name: Celsion Corporation
Award Title: Randomized, Double Blind, Phase Ii Trial of Radiofrequency Ablation +/- Lyso-Thermosensitive Liposomal Doxorubicin (Thermodox) for Colorectal Liver Metastases Greater Than or Equal To 2 Cm Maximum Diameter
Principal Investigator: Wong, David
Sponsor Name: NIH/National Institute of Dental and Craniofacial Research
Award Title: UCLA Dentist-Scientist and oral Health-Researcher Training Program
Principal Investigator: Work, Anna
Sponsor Name: NIH/National Cancer Institute
Award Title: Knowles, Scott Matthew: Antipsca A11 Minibody for Diagnosis and Therapy of Prostate Cancer
Principal Investigator: Zack, Jerome
Sponsor Name: NIH/Center for Scientific Review
Award Title: HIV Infection of Hematopoietic Stem/Progenitor Cells (Hspc) in Bone Marrow